AMGN
Amgen IncNASDAQHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$190.79B
P/E Ratio
24.87
EPS
$14.23
Beta
0.42
52W High
$391.29
52W Low
$253.48
50-Day MA
$359.42
200-Day MA
$316.58
Dividend Yield
2.73%
Profit Margin
21.00%
Forward P/E
15.85
PEG Ratio
2.33
About Amgen Inc
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Fundamentals
| Revenue (TTM) | $36.75B |
| Gross Profit (TTM) | $26.01B |
| EBITDA | $16.62B |
| Operating Margin | 30.50% |
| Return on Equity | 106.10% |
| Return on Assets | 7.93% |
| Revenue/Share (TTM) | $68.31 |
| Book Value | $16.07 |
| Price-to-Book | 21.65 |
| Price-to-Sales (TTM) | 5.19 |
| EV/Revenue | 6.34 |
| EV/EBITDA | 13.79 |
| Quarterly Earnings Growth (YoY) | 112.10% |
| Quarterly Revenue Growth (YoY) | 8.60% |
| Shares Outstanding | $539.07M |
| Float | $537.62M |
| % Insiders | 0.23% |
| % Institutions | 85.30% |
Historical Volatility
HV 10-Day
21.01%
HV 20-Day
24.18%
HV 30-Day
22.40%
HV 60-Day
30.81%
HV Rank
9.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($350.55 target)
4
Strong Buy9
Buy17
Hold2
Sell1
Strong SellData last updated: 3/26/2026